Scrip
US FDA keeps propoxyphene on the market
08 July 2009
Sue Sutter
Bucking the recommendations of its outside advisors and European experts, the US
FDA has decided to keep propoxyphene-containing medicines (such as
Xanodyne's Darvon, Darvocet and generics) on the market. However, the agency ordered stronger label warnings, a medication guide and new safety studies...
Please Login to read the full article.
08 July 2009
Sue Sutter
Please Login to read the full article.
RELATED CONTENT
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
